System leadership recognised that traditional, top-down leadership styles were no longer sufficient on their own, Des Lucey, Head of Market Access for GSK in Ireland, told the Conference in his sponsor address.

The theme – System Leadership–Driven Modernisation of Health and Social Care – really captured the moment we were in.
“The issues you deal with every day are complex, system-wide and shared. They cut across acute and community services, health and social care, and public, private and voluntary sectors. No single organisation, and certainly no single leader, can solve them alone.”
“GSK is proud to support this important event and has done so for many years.”
Mr. Lucey said leadership was collective and distributed, it was relational, grounded in trust, partnership and shared purpose. It was about working across organisational boundaries, disciplines and professions to deliver better outcomes for patients, service users and communities.
“In Ireland, that philosophy finds clear expression in Sláintecareand its programme of reform – bringing together leadership, structural change, cultural change and transformation, and the shift to digital and data-based decision-making. We’ve already seen important progress: Regional Health Areasare now established; workforce reform and digital transformation are underway; and there is greater collaboration across disciplines and systems.
“The Department of Health’s AI for Carestrategy and The Path to Universal Healthcare: Sláintecare & Programme for Government 2025+outline the priorities for the next stage of this journey.
“But as the conference overview acknowledges, there is still some distance to travel. Capacity pressures, chronic disease burden, waiting lists and health inequalities all remain very real, especially for those of you managing hospitals and community services on a daily basis. System leadership in this context means holding the long-term vision while dealing with the immediate pressures.”
Mr. Lucey said that at GSK, their mission was to unite science, technology and talent to get ahead of disease together. “We know we can only do that in partnership with a health and social care system that is itself modernising. We see our role as a constructive partner in three areas that are central to this year’s conference themes – prevention, data-driven innovation, and collaborative implementation.
“First, prevention as a system-level strategy. In an ageing and growing population, with chronic and infectious disease threats placing pressure on services, the only sustainable route is to move more of the system’s focus upstream – to prevent disease where we can and to change its course where we cannot. Prevention is not just a clinical aspiration; it is a modernisation strategy.
“GSK is one of the world’s leading vaccine manufacturers. Here in Ireland, we have been long-standing partners in the childhood immunisation programme, helping to protect the youngest patients against multiple vaccine-preventable diseases. But prevention cannot stop at childhood. Adult immunisation remains a significant opportunity – to protect vulnerable aging people from serious disease, to reduce avoidable hospitalisations, and to support a healthier workforce.
“As we look towards 2027, GSK is committed to continuing to work constructively with the Department of Health and the HSE to support shared public-health priorities, including the further development of adult immunisation. Our focus is on partnership that supports prevention and delivers benefits for patients and communities.
“The theme of “system leadership-driven modernisation” speaks directly to the role of digital and data-based decision-making. Within GSK, we increasingly rely on advanced analytics, AI and human geneticsto identify new targets, design more precise interventions and accelerate discovery. But these tools only reach their full potential when integrated into real-world systems – when data from primary care, hospitals and public health can be used to identify risk earlier, support prevention and direct resources where they are most needed.”
Mr. Lucey said the AI for Careroadmap set an ambitious direction for how AI could support planning, clinical decision-making and service delivery. “Delivering on that ambition will require collaboration between policy-makers, providers, digital and IT teams, patients and partners like GSK. We are committed to working with you to ensure that innovation is safe, ethical and focused on improving outcomes, not technology for its own sake.
“Many of you are already leading programmes that bring together general practice, community services, hospitals and patient representatives to improve care for people living with chronic conditions. Involving patients as partners helps ensure that their experience shapes how care is designed and improved. This collaborative approach creates valuable opportunities to implement programmes effectively and share learning across the health system.
“In GSK Ireland, our work in adult vaccination, including vaccines against shingles and RSV, reflects this same collaborative approach. Working with healthcare professionals and with you as health managers, we can support greater awareness and understanding of adult vaccination and strengthen preventative care across the life course. The shared aim is to protect individuals and communities from vaccine-preventable disease, help people stay well as they age and support healthier, more resilient communities”.
He said collaboration also meantsupporting the organisations that represented patients and communities. “Through our grants and donations programme in Ireland, we support patient organisations and others to deliver initiatives that benefit patients, carers and communities. This support with transparent and responsible funding helps organisations advance their programmes, build capacity, raise disease awareness and address unmet need, while respecting their independence and expertise.
“As sponsors, we are very conscious that our role today is to support the conversations you are having. We recognise that public trust, transparency and responsible collaboration are essential when industry partners engage with the health system. We are committed to working within the healthcare ecosystem to ensure that innovation and investment translate into tangible health outcomesfor patients and communities.
“In closing, I want to acknowledge the leadership you demonstrate – often under intense pressure – as you navigate this journey from aspiration to implementation. System leadership can sound abstract, but for you it is lived out in how you and your teams work together every day.
“At GSK, we will continue to be ambitious for patients in Ireland. We will continue to invest in prevention, in science and technology, and in partnerships that help “ We share your belief that a modern health and social care system is one where prevention is prioritised, care is more integrated and equitable, and innovation is harnessed in a way that strengthens the system for the long term.
That spirit of partnership and shared purpose is ultimately how we will make the greatest difference for patients, for communities and for the health service as a whole.”

